StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Share Consolidation

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Jun 04, 2021 9:26pm

106 Views

Post# 33335206

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Share Consolidation

Lith I'm no basher here,I had a concern and voiced it. Look at all the comments prior to the vote of 2019 same comments were made, then again 2020 same comments made, split was to uplist, well we did the split and came nowhere close to uplist, right after splitting we handed out more shares to finance and then even more to buy HC, who's to say we aren't doing it again to allow more financing? And what will you say if that happens, well we need money for whatever the company decides then rinse and repeat.

LithLover wrote: And what benefit is a 2:1 split unless it gives them an opportunity to uplist? None. Just attempts by bashers to pile on and try to create doubt and fear to allow them to short and distort.

We see right through them so its ineffective as always and a waste of time.

Their families must be so proud that they attack a cancer detection company.

Liked2Think wrote: Rebecca says the reverse split wont occure before the Care deal is signed and done with.

Yes I am taking her for her word I suppose but the time table doesnt make sense.

Care agreed to the buyout yes at a higher SP but they would had done that believing the price woudl go up from there. They arent dumb people at Care. They know if they basically forced Stage to do the reverse split so they could get the price back up to a buck so that then Care woudl be given those shares they would actually lose value then.

Say they agreed to the buy out when the price was at a dollar.
Its at 50 cents today.
Say Stage does the 2:1 now and gives Care the number of shares at the new price
Its not like Care can sell those shares right away nor do they get all of the shares right away. Plus the extra extra they get for perfmormance milestones wouldnt happen.
Why wouldnt it happen? Because if Stage does the RS and then gives Care the shares it will destroy the SP. It will fall back to under 50 cents all over again.

So my question is to what benefit would it be to Care to have Stage do the RS before they give them the shares? Absolutely NOTHING.